Health Periodical Corner: 2013

Monday, September 2, 2013

Not your grandmother's gym class

By Dorene Internicola NEW YORK (Reuters) - Physical education in the United States has come a long way since the one-size-fits-all regimen of jumping jacks and rope climbing that was the bane of the baby boomer generation. Today, where children learn can determine the type of fitness lessons they receive. ... Original Source

Da saúde bucal à coluna vertebral - um artigo do Instituto Zanet

SÃO PAULO, 2 de setembro de 2013 /PRNewswire/ -- O artigo dos Profs. Drs. Caio Zanet e Tiago Zanet mostra que consultar o dentista deixou de ser apenas rotina para tratamento dos dentes, para se estender ao controle da saúde do corpo.

"Na animação 'Pinoquio', de Walt Disney, o marceneiro Gepeto constrói um marionete em madeira, com cabeça, ombros, braços, quadril, pernas e, para unir todas essas partes, uma vareta ligando a cabeça aos pés.

Esse personagem nos orienta bem sobre como nosso corpo é dividido em cabeça, ombros e membros superiores, tronco, quadril e membros inferiores. Constituída de ossos intercalados por cartilagens, sustentados por diversos músculos, a coluna vertebral une todas essas partes, fazendo a união indireta do tornozelo ao maior osso móvel da cabeça: a mandíbula.

Um dente ausente, mal posicionado ou uma prótese mal adaptada podem interferir na postura? Sim. Ao observarmos como nosso corpo está interconectado, entendemos por que uma pequena alteração na mordida acaba influindo na posição da mandíbula que, por sua vez, afeta músculos e coluna vertebral, até chegar ao tornozelo, prejudicando a postura.

Imaginemos: um indivíduo com a falta de um dente do lado direito perderá a eficiência da mastigação nessa região e passará a mastigar mais do lado esquerdo. O aumento dessa mastigação praticamente unilateral faz com que os músculos desse lado fiquem hipertrofiados. O trapézio (formado pelos músculos dos ombro e das costas), também indiretamente relacionado à mastigação, ficará encurtado devido ao trabalho, o ombro esquerdo elevado e a cabeça inclinada para a esquerda. Porém, o sistema de equilíbrio do corpo forçará a cabeça a ter sua posição alinhada. Assim, a coluna ficará torta e o indivíduo sentirá dor.

Será que eu tenho essa interferência? Simples. À frente de um espelho retangular, a uma distância de um metro, compare a linha reta da moldura com o desnivelamento de seus ombros, de sua cabeça e de seus olhos. Se algum lado estiver mais alto que o outro, você pode ter sim uma interferência na mordida.

Como descobrir onde está esta interferência? Por meio de manobras semiotécnicas, exames radiográficos e fotos posturais realizadas por cirurgião dentista especializado, capaz de desvendar o local da interferência e indicar o melhor tratamento."

Profs. Drs. Tiago Gorgulho Zanet (tgzanet@institutozanet.com.br) e Caio Gorgulho Zanet (caiogzanet@hotmail.com) são cirurgiões-dentistas e diretores clínicos do Instituto Zanet (www.institutozanet.com.br +55 11 2271-5156), onde comandam uma equipe multidisciplinar.

CONTATOS PARA A IMPRENSA
Estúdio ô+sch - www.osch.com.br
Claudia Megre Rachid
claudia@osch.com.br
Irina Schneider
irina@osch.com.br
+55 (11) 99907-3960

FONTE Instituto Zanet Odondologia Avançada

SOURCE Instituto Zanet Odondologia Avançada

RELATED LINKS
http://www.institutozanet.com.br

Source: www.prnewswire.com

New platters introduced by Sai Bhoj for the festive season

While sticking to a purely vegetarian menu, the food chain will serve new recipes and also offer discounts.

(PRWeb September 02, 2013)

Read the full story at http://www.prweb.com/releases/2013/9/prweb11082249.htm

Here is the full post.

Mellow music may stave off road rage

Tune in to some mellow music in the car and there's a chance you'll be less susceptible to road rage, researchers claim. Source

Sunday, September 1, 2013

UK is 'addictions capital of Europe'

The UK is the "addictions capital of Europe" because of a failure to tackle the trade in "legal highs", heroin addiction and cheap alcohol, a think tank warns. Continue reading...

Radiation readings spike at water tank at Japan's ruined nuclear plant

By Tetsushi Kajimoto TOKYO (Reuters) - Radiation near a tank holding highly contaminated water at Japan's crippled Fukushima nuclear plant has spiked 18-fold, the plant's operator said on Sunday, highlighting the struggle to bring the crisis under control after more than two years. Radiation of 1,800 millisieverts per hour - enough to kill an exposed person in four hours - was detected near the bottom of one storage tank on Saturday, Tokyo Electric Power Co, also known as Tepco, said. An August 22 readings measured radiation of 100 millisieverts per hour at the same tank. ...

Saturday, August 31, 2013

Actos Lawsuits Move Forward Following Latest Status Conference in...

The Firm is currently offering confidential Actos lawsuit evaluations to long-term users of Actos who have been diagnosed with bladder cancer.

(PRWeb August 31, 2013)

Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-bladder-cancer/prweb11079665.htm

Read the full article.

'Legal high' bans must be 'faster'

'Legal high' bans must be 'faster'
Efforts to clamp down on the sale of dangerous substances known as legal highs are failing, a think-tank close to the government warns.

Get Rid of Cellulite on Thighs - Anti Cellulite

Cellulite has been a nightmare for so many women. It gives the skin a horrible dimpled effect in those problem areas and many women will go to great lengths to reduce cellulite just to have ... Read more...

Isis Reports Interim Phase 2 Data on ISIS-APOCIII Rx as a Single Agent in Patients With Very High to Severely High Triglycerides

Conference call webcast and slide presentation Tuesday, Sept. 3, 11:30 a.m. ET at www.isispharm.com

Isis Pharmaceuticals, Inc. (PRNewsFoto/Isis Pharmaceuticals, Inc.)

CARLSBAD, Calif., Aug. 31, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced interim data from an ongoing Phase 2 study of ISIS-APOCIII_Rx as a monotherapy in patients with very high to severely high triglycerides. These data were presented today by Dr. Daniel Gaudet at a PACE session occurring concurrently with the European Society of Cardiology in Amsterdam. In this study, patients treated with ISIS-APOCIII_Rx achieved statistically significant mean reductions of up to 79 percent in apolipoprotein C-III (apoC-III) and up to 75 percent in triglycerides. In addition, patients treated with ISIS-APOCIII_Rx achieved statistically significant mean increases of up to 57 percent in high-density lipoprotein cholesterol (HDL-C), the 'good' cholesterol. Patients also achieved up to 89 percent mean reduction in apoC-III-associated very low-density lipoprotein (VLDL) particles.

(Logo: http://photos.prnewswire.com/prnh/20130807/LA60006LOGO)

"Patients with very high levels of triglycerides experience a significant number of health problems, including type 2 diabetes, obesity, cardiovascular disease and, for patients with severely elevated triglycerides, pancreatitis. For these patients, there are very limited treatment options and what is needed is a much more effective drug that can be used as a single agent or in combination with other triglyceride-lowering agents," said Daniel Gaudet, M.D., Ph.D., from the department of medicine, University of Montreal and scientific director, Genome Quebec Biobank Technology Center. "The comprehensive Phase 2 data reported this summer demonstrate that ISIS-APOCIII_Rx has the potential to fill this need."

The monotherapy portion of the ongoing Phase 2 study of ISIS-APOCIII_Rx is a double-blind, randomized, placebo-controlled 13-week study designed to assess the safety and activity of ISIS-APOCIII_Rx in patients with very high to severely high triglyceride levels (between 440 and 2,000 mg/dL). The data reported today is an interim analysis of 28 patients who completed 13 weeks of treatment with ISIS-APOCIII_Rx or placebo. In this study, patients treated with ISIS-APOCIII_Rx experienced dose-dependent, robust and prolonged, mean percent reductions from baseline in apoC-III, triglycerides and apoC-III-associated VLDL particles. Furthermore, these patients demonstrated a rapid, prolonged and statistically significant mean percent increase from baseline in HDL-C.

Table 1: ISIS-APOCIII_Rx Produced Statistically Significant Reductions of Triglycerides, ApoC-III and ApoC-III-associated VLDL as a Single Agent in a Phase 2 Study in Patients with Very High to Severely High Triglyceride Levels. Mean % Changes From Baseline at Primary Endpoint.*

Placebo

(n=9)

ISIS-APOCIII_Rx

100 mg (n=9)

ISIS-APOCIII_Rx

200 mg (n=5)

ISIS-APOCIII_Rx

300 mg (n=5)

ApoC-III

+5%

-43%

(p=0.04)

-72%

(p=0.004)

-79%

(p=0.003)

Triglycerides

+26%

-31%

(p=0.08)

-65%

(p=0.02)

-75%

(p=0.004)

ApoC-III VLDL

+19%

-27%

(p=0.17)

-73%

(p=0.003)

-89%

(p=0.004)

HDL-C

+3%

+30%

(p=0.08)

+51%

(p=0.002)

+57%

(p=0.001)

non-HDL

+17%

-8%

(p=0.16)

-5%

(p=0.36)

-39%

(p=0.007)

P value = vs. placebo *Interim analysis

In the ongoing study, patients received 100 mg, 200 mg or 300 mg dose of ISIS-APOCIII_Rx, or placebo via weekly subcutaneous injections. In this interim analysis, patients had an average fasting triglyceride level of 602 mg/dL with incoming triglyceride levels up to 1,822 mg/dL. In this study ISIS-APOCIII_Rx was found to be generally safe and well tolerated. The most common adverse event (AE) was injection site reactions, which were infrequent, predominantly mild and typically resolved rapidly. There were no flu-like symptoms, no treatment-related elevations of liver enzymes greater than three times upper limit of normal, no abnormalities in renal function and no clinically meaningful changes in other laboratory values.

"We are pleased with the performance of ISIS-APOCIII_Rx to date. We have now demonstrated that ISIS-APOCIII_Rx is equally effective in patients with high to severely high triglycerides as well as in patients with high triglycerides and type 2 diabetes. We have demonstrated that ISIS-APOCIII_Rx can work equally well as a single agent and in combination with fibrates to produce significant reductions in apoC-III and triglycerides, and increases in HDL-C. In addition, the positive effect of ISIS-APOCIII_Rx treatment on lipid parameters, improvements in glucose control and trends toward improvements in insulin sensitivity, suggest that ISIS-APOCIII_Rx could have a very attractive therapeutic profile for patients with severely high triglycerides, who often also have diabetes or metabolic syndrome," said Richard Geary, Ph.D., senior vice president of development at Isis. "We look forward to discussing our Phase 3 plans with regulators and moving rapidly into a Phase 3 program next year in patients with severely high triglycerides."

ISIS-APOCIII_Rx is an antisense drug intended to treat patients with severely high triglycerides either as a single agent or in combination with other triglyceride-lowering agents. ISIS-APOCIII_Rx targets apoC-III, a gene produced in the liver that plays a central role in the regulation of serum triglycerides. Humans who do not produce apoC-III have lower levels of triglycerides and lower instances of cardiovascular disease. In clinical studies, patients with lower levels of apoC-III and triglycerides exhibit lower cardiovascular event rates. Humans with elevated levels of apoC-III have increased dyslipidemia associated with multiple metabolic abnormalities, such as insulin resistance and/or metabolic syndrome. In addition, the prevalence of type 2 diabetes is increased in patients with elevated triglycerides.

Conference Call
At 11:30 a.m. Eastern Time Tuesday, Sept. 3, 2013, Isis will conduct a live webcast and slide presentation conference call to discuss the positive Phase 2 data presented today. Interested parties may listen to the call by dialing 866-652-5200, or access the webcast with or without audio at www.isispharm.com. A webcast replay will be available for a limited time at the same address.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 29 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH. Genzyme is also pursuing marketing approval of KYNAMRO in other markets. Isis' patents provide strong and extensive protection for its drugs and technology. Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding the discovery, development, and potential of drugs for cardiovascular diseases, and the development, activity, therapeutic potential and safety of ISIS-APOCIII_Rx. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2012 and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc. KYNAMRO™ is a trademark of Genzyme Corporation.

SOURCE Isis Pharmaceuticals, Inc.

Friday, August 30, 2013

Dr. Schaller of Naples, FL has been named a Patients' Choice Award Winner for 2012

Dr. Schaller of Naples, FL has been named a Patients' Choice Award Winner for 2012. (PRNewsFoto/American Registry)

NAPLES, Fla., Aug. 30, 2013 /PRNewswire-USNewswire/ -- Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. James Schaller, MD, MAR.

(Photo: http://photos.prnewswire.com/prnh/20130830/DC72230)

In fact, of the nation's 870,000 active physicians and dentists, just five percent consistently received top scores from their patients on sites like Vitals (http://www.vitals.com), qualifying them for this honor in 2012.

Millions of patients go online each year to rate their doctors on various components of care, including accuracy of their diagnosis, the amount of time they spent with the doctor, and the doctor's bedside manner and follow-up care. Patients' Choice reviews these rankings and other quality measures to compile its yearly list of award winners.

Dr. James Schaller, MD, MAR commented on the recognition: "I'm so honored to receive an award that's based on how my patients view the quality of care I provide. I strive each day to exceed my patients' expectations, and I'm grateful that they've recognized my efforts."

About James Schaller, MD, MAR: a short profile by and about the honoree:

Dr. Schaller offers unique care to patients from all over the world who have failed the best physicians and alternative healers, who seek a full time reader/researcher who has no interest in position or merely talk about 20 genres of healing--he publishes in them. With 50 books and papers in medicine's top journals, Dr. Schaller has twenty more books on deck and a passion to help the helpless suffering from non-surgical non-cancer treatment failure. His current interests to help: tick infections, biofilm, severe fatigue, mystery illness, herbal/plant oil medicine, fibromyalgia and inflammation.

For more information on this Patients' Choice Award winner, please visit Dr. James Schaller, MD, MAR's profile on PatientsChoice.org.

Following the publication of James Schaller, MD, MAR's selection for the Patient's Choice Award, American Registry seconded the honor and added Dr. Schaller to The Registry™ of Business Excellence. An exclusive recognition plaque has been designed to commemorate the honor. The doctor's custom wall plaque is shown here.

For more information on Dr. James Schaller, MD, MAR, located in Naples, FL, please call 239-263-0133, or visit www.personalconsult.com.

This press release was written by American Registry, LLC with approval by and/or contributions from Dr. Schaller and was distributed by PR Newswire, a subsidiary of UBM plc.

Patients' Choice provides in-depth information on doctors in your area who have been recognized and awarded for outstanding patient care and expertise. The Patients' Choice Award is the honor roll of physicians who have received the highest ratings by their patients.

American Registry, LLC, recognizes excellence in top businesses and professionals. The Registry™ includes over 2 million significant business and professional recognitions. For more information, search The Registry at http://www.americanregistry.com.

Contact Info:
Dr. James Schaller, MD, MAR
Phone: 239-263-0133
Email Address: jameslschallermd@gmail.com

SOURCE American Registry

RELATED LINKS
http://www.americanregistry.com

Source: www.prnewswire.com

Team Cellucor Athlete Wins 2nd Place for WBFF Pro Diva Fitness...

The Worldwide Beauty and Fitness Organization (WBFF) hosted its 2013 World Championships at the Planet Hollywood Resort and Casino in Las Vegas, NV. Cellucor Athlete, Jen Jewell, won 2nd place in the...

(PRWeb August 30, 2013)

Read the full story at http://www.prweb.com/releases/2013/8/prweb11076951.htm

Will sleeping with makeup on actually age your skin?

Lecturing people about taking their makeup off before bed is the average beauty editor’s favourite pastime (second only to hysterical evangelism about sunscreen). But don’t worry—this isn’t going to be a lecture. Instead, […]

The post Will sleeping with makeup on actually age your skin? appeared first on beautyeditor.

Lecturing people about taking their makeup off before bed is the average beauty editor’s favourite pastime (second only to hysterical evangelism about sunscreen).

But don’t worry—this isn’t going to be a lecture. Instead, I want to talk about some of the claims coming out of the latest Daily Mail sensationalist beauty piece, about how 40-year-old writer Anna Pursglove aged herself by an incredible 10 years in four weeks… all, apparently, from wearing her makeup to bed.

The experiment was inspired by a recent stat (source unknown) that found a third of women sleep with makeup on at least twice per week. Author Anna wanted to know why, when it’s common knowledge that it’s bad for your skin—so she decided to not wash her face at night for a entire month! Actually, it’s even worse, as she further clarifies:

“I would give my face a cursory wash in the shower each morning but I would be allowed to use none of my usual cleansing creams, and would have to reapply new make-up over the remnants of the old each day.”

I’m not certain, but I think that means she only washed with water… so basically, she didn’t really clean her face AT ALL. Nor did she apply moisturizer. Nor did she exfoliate. (More on those key facts in a second.)

Here’s what Anna looked like before the experiment:

She’s wearing makeup here, so it’s impossible to really assess the true condition of her skin going into this. To me, it looks like she has some minor inflammation (redness), fine lines, sagging and pigmentation.

Here’s what she looked like, with no makeup at all, after the four-week test:

So this is what 10 years older looks like—at least according to the dermatologist in charge of the assessment.

Not good, but in a way there are aspects of her skin that I actually think look better in the “after” picture! Yes, there is a ton of redness and all of those inflamed patches, but I also think her skin has a healthier colour and appears firmer, the pores aren’t so visible and the under-eye area doesn’t look as puffy. Then again, it could just be that I don’t like her makeup job in the “before” photo—that under-eye mascara really drags her face down and I have no idea what’s happening above her eyebrows.

But really, it’s impossible to tell just from photos because the lighting and angles here are not consistent. So I want to examine all of the problems the dermatologist identified after a month of this “routine,” one by one.

Does sleeping with makeup on give you drier skin?

Anna’s skin was very flaky and dry by the end of this, particularly on her cheeks, and she had cracking at the corners of her lips. The derm identified a five percent decrease in moisture levels, which resulted in a 10 to 20 percent worsening in skin texture.

Well, duh! She didn’t use moisturizer at all for a month (and I guess no lip balm either), so how is this the left-on makeup’s fault? When women go the occasional night without washing their faces, I guarantee that 99 percent of them are cleansing properly, following with moisturizer, in the morning.

So rather than a study of what happens when you don’t wash off makeup, I think this test is actually reflective of what happens when you don’t moisturize. (To be clear, I’m not saying that everyone needs moisturizer, either—this summer, I’ve been using just my super-light Consonant HydrExtreme serum and my skin has been absolutely fine—but if you have dry skin already, you certainly don’t want to deprive it of something more nourishing.)

Consonant HydrExtreme Extreme Hydration Booster, $149.00

The other thing to mention is exfoliating, which many women do with manual or chemical exfoliants, or just by the act of rubbing with a face cloth or towel after washing. If Anna wasn’t doing this, then it’s no wonder that the dead skin cells built up and contributed to the dryness, along with a duller texture.

Does sleeping with makeup on give you wrinkles?

Another claim by the dermatologist was that Anna had developed deeper wrinkles, not on her forehead but on the left and right sides of her face. I can’t tell from looking at the pictures, but this is where her skin became driest—so it makes complete sense that the wrinkles would become more visible there too.

The whole moisturizer avoidance thing is a CLASSIC skincare company trick to get you to believe that their products are doing something. Not all of them, but many will run studies where the participants have to avoid moisturizer completely for a week or so before starting the trial of the new product. Obviously there’s going to be an improvement regardless of what fancy ingredients are in it, because moisture plumps up wrinkles. Simple as that.

So again, it’s not the makeup’s fault—just common sense that if you skip a night of moisturizing, then your skin won’t be as plumped-up in the morning.

Does sleeping with makeup on increase redness and irritation?

Anna’s already sensitive skin became two percent more red, which the derm said was a sign of irritation. The makeup forms a barrier over the skin that locks in irritants and keeps out moisture, exacerbating any allergic reactions.

I absolutely agree—although two percent is not very much and this is from an entire month of the behaviour (which is not a realistic way that women care for their skin). Still, I think that us sensitive types need to be very careful whether it’s day OR night. I’ve had allergic reactions develop out of nowhere, even with products I’d been consistently using (like Touche Éclat!), so leaving them on overnight could increase the risk.

The other thing to consider is your eyelashes. Without properly removing her mascara, Anna’s started clumping together, she developed eyelash dandruff and even woke up with a swollen eye one morning (due to a mascara-coated lash getting caught in it). God forbid, you could even develop an eye infection. That alone is enough reason for me to diligently remove my makeup every night!

The best combo I’ve found, that gets absolutely every speck of mascara off, is my no-rinse Bioderma micellar cleanser (in Canada it’s called Sensibio):

Bioderma Créaline H2O Ultra-Mild Non-Rinse Cleanser for Face & Eyes (Normal to Sensitive Skin), $39.00

With my trusty designer cotton pads:

Shiseido Facial Cotton, $9.00

I was using these products just for removing eye makeup, but that morphed into doing my whole face with them instead of regular cleanser! It works, it’s easy and it feels like less effort than having to splash around in the sink. I don’t think I’ve washed my face at night with gel cleanser for probably four months!

I also really love these:

Yes to Cucumbers Facial Towelettes, $5.99

They’re really gentle and work great at removing even stubborn eye makeup, but won’t dry out your skin.

Does sleeping with makeup give you larger pores?

Anna’s pores became five percent larger, thanks to the build-up of makeup clogging and stretching them, making them more noticeable. The derm said it was a sign that her skin had aged over the month, giving this as the reason:

“Older people naturally have larger pores because, with age, elasticity decreases so the structures that support the skin, and keep pores tight, become slacker.”

Huh? I don’t get how elasticity can be affected in just one month from not washing your face. But still—I am in agreement that leaving on anything that is potentially pore-clogging isn’t the best idea. People with acne-prone skin need to be especially careful about removing all traces of makeup (along with the day’s oil left on skin). Even changing your pillowcases more often can make a difference.

The bottom line about sleeping with makeup on

Don’t get me wrong; I’m not advocating sleeping with makeup on by any means. But hey, it happens! And I don’t think it’s the horror show that the Daily Mail is suggesting here–at least not if you’re only doing it on an occasional basis, which I think is how it happens with most of us.

Plus, like I said, most of us double-up on cleansing and moisturizing the day after we sleep with makeup on—not pile more on over top! That’s just not realistic behaviour. I don’t personally know any women who don’t wash their faces or use moisturizer, EVER—but if they’re out there, I’m guessing they probably don’t wear makeup either. So the chance of clogging pores and developing infections and allergies is much less.

As far as aging goes, skipping moisturizer and leaving dry skin to get drier and drier appears to be the worse skin sin than the occasional late night without cleansing.

Let’s talk about this:

Do you ever sleep with makeup on or are you religious about your routine?
What do you make of Anna’s experiment?
Do you think skipping moisturizer is worse than sleeping with makeup on?

The post Will sleeping with makeup on actually age your skin? appeared first on beautyeditor.

Corbett to Sebelius: Need Response to Save CHIP for Pennsylvania's Children

HARRISBURG, Pa., Aug. 30, 2013 /PRNewswire-USNewswire/ -- Governor Tom Corbett sent a third letter today to U.S. Department of Health & Human Services Secretary Kathleen Sebelius asking her not to involuntarily move children currently covered under Pennsylvania's Children's Health Insurance Program (PA CHIP) into Medicaid.

The forced move is a requirement of the Affordable Care Act and would be effective Jan. 1, 2014.

Corbett has argued that PA CHIP is a national model that provides not only a robust array of health insurance benefits, but also access to more doctors and hospitals than traditional Medicaid. He's also expressed concerns that moving children from PA CHIP's commercial insurance platform to Medicaid could cause disruptions in their relationships with their health care providers and delays in their ability to access care.

For more information or to read previous correspondence with HHS, visit www.insurance.pa.gov and click on "Affordable Care Act News."

Media contact: Christine Cronkright, Governor's Office, 717-783-1116

Editor's Note: Today's letter is included below. Previous letters on this subject are posted on www.insurance.pa.gov under the "Affordable Care Act News" button.

Aug. 30, 2013

Dear Secretary Sebelius:

As you know, I am very concerned by the U.S. Department of Health and Human Services' (HHS) contention that the Affordable Care Act (ACA) requires certain children in Pennsylvania's Children's Health Insurance Program (PA CHIP) be involuntarily moved into Medicaid.

I communicated this concern to you during our face-to-face meeting on April 2, 2013, in Washington D.C. and in subsequent letters to you dated May 30, 2013, and June 26, 2013. In fact, in all three instances, I specifically asked for approval from the Obama Administration to allow Pennsylvania to preserve PA CHIP for the children and families that currently enjoy its benefits. I have attached copies of those letters that fully explain the Commonwealth's position, why we believe you have the authority to grant this approval and why any ruling to the contrary would directly violate NFIB v. Sebelius.

As a former Governor, you understand the need for timely and definitive answers, yet to date I have not received a response from you to my requests. This prolonged absence of a clear response has created significant operational and systems challenges for Pennsylvania. Any further delays in receiving a response from you only increases the risk of creating additional healthcare disruption for thousands of Pennsylvania children and families.

I ask that you respond in writing to my request by no later than September 6, 2013. I firmly believe that PA CHIP is the right program to meet the healthcare needs of Pennsylvania children. I remain committed to working with you and Pennsylvania families to preserve this great program and ensure all Pennsylvania children have access to quality and affordable healthcare coverage.

Sincerely,

Tom Corbett
Governor

SOURCE Pennsylvania Office of the Governor

RELATED LINKS
http://www.governor.state.pa.us

Source: www.prnewswire.com

Clever people don't smoke

Better educated middle-aged Americans are less likely to smoke and more apt to be physically active than their less educated peers, according to a new study. Continue reading...

Fresh Life Eau de Parfum

[product of the day] Fresh Life Eau de Parfum $38 USD / $44 CAD for 30mL and $80 USD / $92 CAD for 100mL Available November 2013 at Sephora 100mL Pre-order now at QVC Copyright © Beautezine, 2013. | Original Post | No comment | Twitter | Facebook Categories: Product of the Day Tags: Fresh, […]

[product of the day]
Fresh Life Eau de Parfum
$38 USD / $44 CAD for 30mL and $80 USD / $92 CAD for 100mL

Available November 2013 at Sephora
100mL Pre-order now at QVC

Copyright © Beautezine, 2013. | Original Post | No comment | Twitter | Facebook
Categories: Product of the Day
Tags: Fresh, Fresh Life Eau de Parfum

Read the full article.

Cardiome anuncia su presencia en el Congreso ESC 2013 en Ámsterdam

VANCOUVER, August 30, 2013 /PRNewswire/ --

NASDAQ: CRME TSX: COM

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ha anunciado hoy que la compañía tendrá un expositor y que patrocinará un simposio satélite en el próximo Congreso ESC 2013 celebrado en Ámsterdam, Países Bajos, del 31 de agosto al 4 de septiembre.

Esta conferencia anual está organizada por la Sociedad Europea de Cardiología y se centra en la ciencia, gestión y prevención de la enfermedad cardiovascular.

"Estamos encantados de poder participar de nuevo en el prestigioso congreso anual de la Sociedad Europea de Cardiología", dijo Karim Lalji, director comercial de Cardiome. "Este es el primero de una serie de encuentros importantes en Europa en el que Cardiome planea participar activamente mientras continuamos para ejecutar la estrategia de comercialización para BRINAVESS".

El simposio satélite, titulado "Recent Advances in the Management of Atrial Fibrillation" se celebrará el sábado, 31 de agosto, de 13.00 a 14.00 en la sala Skopje en el Amsterdam RAI Exhibition and Convention Center. El programa del simposio es el siguiente:

Portavoces: H. Crijns (Maastrict, NL) y J.L. Merino (Madrid, ES)

13:05 - 13:20: D. Atar (Oslo, NO); Las directrices ESC 2012 para la fibrilación atrial
13:20 - 13:35: P. Kirchhof (Birmingham, UK); Aspectos económicos de la fibrilación atrial
13:35 - 13:50: J. Hartikainen (Kuopio, FI); Experiencia en la vida real con vernakalant:
¿ Cuál es el paciente adecuado para este fármaco?
13:50 - 14:00: Conclusión y declaraciones de cierre

Un webcast del simposio estará disponible al público en el sitio web 365 del Congreso ESC (http://congress365.escardio.org/home.aspx) hasta septiembre de 2014.

Acerca de Cardiome Pharma Corp.

Cardiome Pharma Corp. es una compañía biofarmacéutica dedicada al descubrimiento, desarrollo y comercializacion de nuevas terapias que mejorarán la salud de los pacientes en todo el mundo. Cardiome tiene un producto comercializado, BRINAVESS^[TM] (vernakalant IV), aprobado en Europa y otros territorios para la rápida conversión de fibrilación atrial de aparición reciente para el ritmo sinusal en adultos.

Cardiome cotiza en NASDAQ Capital Market (CRME) y la Toronto Stock Exchange (COM). Para más información, visite nuestro sitio web en http://www.cardiome.com.

Nota cautelar sobre las declaraciones prospectivas
Determinadas declaraciones de este comunicado contienen declaraciones prospectivas dentro de la Private Securities Litigation Reform Act de 1995 o información prospectiva dentro de la legislación de valores canadiense aplicable que no se basan en hechos históricos, incluyendo, entre otras, declaraciones que contienen las palabras "cree", "podría", "planea", "podrá", "estima", "continúa", "anticipa", "pretende", "espera" y expresiones similares. Las declaraciones prospectivas podrían implicar, entre otros, comentarios con respecto a nuestros objetivos y prioridades para el resto de 2013 y más allá, nuestras estrategias o acciones futuras, nuestros objetivos, expectativas para nuestra condición financiera y los resultados de, o perspectiva para, nuestras operaciones, investigación y desarrollo y desarrollo de productos y fármacos. Dichas declaraciones prospectivas implican riesgos conocidos y desconocidos, incertidumbres y otros factores que podrían causar que los resultados reales, eventos o desarrollos sean materialmente diferentes de los resultados, eventos o desarrollos futuros expresados o implícitos por dichas declaraciones prospectivas. Muchos riesgos conocidos, incertidumbres y otros factores se tienen en cuenta como parte de nuestras suposiciones subyacentes a estas declaraciones prospectivas e incluyen, entre otros, los siguientes: las condiciones económicas y empresariales generales en Estados Unidos, Canadá, Europa y otras regiones en las que operamos; la demanda de mercado; los cambios tecnológicos que podrían afectar a nuestros productos existentes o nuestra capacidad para desarrollar y comercializar productos futuros; la competencia; la legislación gubernamental existente y regulaciones y cambios en, o el fallo al cumplir con, la legislación y regulaciones gubernamentales; la disponibilidad de la cobertura de reembolso financiero de contribuyentes gubernamentales y de terceros para productos y tratamientos relacionados; los resultados negativos o retrasos no esperados en procesos de desarrollo de producto clínicos y preclínicos; los hallazgos negativos relacionados con la seguridad y/o eficacia de nuestros productos o productos; las decisiones, y el momento de las decisiones, hechas por las agencias reguladoras de salud en cuanto a la aprobación de nuestra tecnología y productos; el requisito de financiación para expandir las actividades comerciales; y cualquier otro factor que podría afectar a nuestro rendimiento. Además, nuestro negocio está sujeto a determinados riesgos operativos que podrían causar que cualquier resultado expresado o implícito por las declaraciones prospectivas en esta presentación difiera materialmente de los resultados reales. Estos riesgos operativos incluyen: nuestra capacidad de atraer y retener a personal cualificado; nuestra capacidad de completar con éxito desarrollo clínico y preclínico de nuestros productos; cambios en nuestra estrategia empresarial o planes de desarrollo; cuestiones de propiedad intelectual, incluyendo la inejecución o pérdida de la protección de patente resultante de retos de terceros a nuestras patentes; aceptación de mercado de nuestra tecnología y productos; nuestra capacidad para fabricar, comercializar y vender con éxito nuestros productos; la disponibilidad de capital para financiar nuestras actividades; y cualquier otro factor descrito en detalle en nuestras presentaciones a la Comisión de Bolsa y Valores disponibles en http://www.sec.gov y las autoridades regulatorias de valores canadienses en http://www.sedar.com. Dados estos riesgos, incertidumbres y factores, se recomienda que no deposite una confianza indebida en dichas declaraciones e información prospectiva, que se califican en su totalidad por esta declaración cautelar. Todas las declaraciones e información prospectiva efectuadas aquí se basan en nuestras expectativas actuales y no asumimos ninguna obligación para revisar o actualizar dichas declaraciones prospectivas para reflejar eventos o circunstancias posteriores, excepto que se requiera por ley.

Para más información:
Relaciones de inversor de Cardiome
+1-(604)-676-6993 o llamada gratuita: 1-800-330-9928
E-mail: ir@cardiome.com

SOURCE Cardiome Pharma Corp.

Source: www.prnewswire.com

Thursday, August 29, 2013

New vaccine for typhoid fever

New vaccine for typhoid fever
An Indian pharmaceutical company has developed the world's first clinically proven typhoid vaccine, giving long-term protection to infants and adults.

Take the Bite Out of Labor Day

ST. LOUIS, Aug. 29, 2013 /PRNewswire/ -- Nothing puts a damper on end-of-summer picnics and campouts faster than biting bugs. Unfortunately, mosquitoes and other insect pests come with the summertime territory. You can keep pesky – and sometimes dangerous – bugs from ruining your time outdoors over the long Labor Day weekend by taking three steps for complete protection: Treat yourself, treat the yard and treat your deck, patio or campsite. By creating a Bite-Free Zone™ of protection during your festivities, you can help keep your family safe from mosquitoes and the diseases they may carry.

1. First, use a personal insect repellent as your main line of defense against biting bugs. The Centers for Disease Control and Prevention recommends using a repellent when spending time outdoors as a highly effective way to minimize risk of contracting West Nile virus and other mosquito-borne illnesses. Personal repellents are available in a variety of application methods and active ingredients, ranging from the familiar DEET to newer ingredients like oil of lemon eucalyptus.

DEET-based insect repellents, such as Unscented Backwoods Cutter® and Cutter® All Family® insect repellents, are recommended for those who plan to spend longer periods of time outdoors in more heavily infested conditions. Length of protection depends on the percentage of DEET in the product. Formulas with 30 percent concentrations or lower can be used on children ages 2 months and older.
Oil of Lemon Eucalyptus, derived from the leaves of the Eucalyptus citriodora tree, naturally repels mosquitoes for up to six hours. You can use oil of lemon eucalyptus-based products, like Cutter® Lemon Eucalyptus Insect Repellent, on children 3 years and older.
Geraniol-based products, such as Cutter® Natural Insect Repellent, utilize the inherent repellent properties of the geranium flower to repel mosquitoes and other nuisance pests for hours.

Did you know that mosquitoes can detect an unprotected area of skin the size of a dime? In addition to using a personal repellent, you can limit your exposure by dressing strategically: Wear long sleeves and long pants outdoors when mosquitoes are most active (around dusk and dawn). Avoid using scented soaps, perfumes and hair spray when you know you're going to be outside for an extended period of time.

2. Second, treat your lawn with an all-purpose, EPA-registered lawn insecticide with residual efficacy against mosquitoes. Cutter® Backyard™ Bug Control Spray Concentrate, for example, creates a barrier against biting bugs in your lawn for up to 8 weeks of control. Spray over the entire yard, including ornamental trees, shrubs and flowers, and onto outdoor surfaces. Just remember to spray early enough to allow the product to completely dry before your Labor Day backyard get-together.

Mosquitoes breed near sources of water. Be proactive in preventing mosquitoes from congregating in your lawn. Remove standing water in flower pots, on pool covers and in outdoor pet bowls. Make sure your gutters are clean and unclogged and that your downspouts drain effectively so puddles aren't left behind after it rains. Mow your lawn regularly to keep mosquitoes from seeking refuge on tall grass.

3. Last, use an area repellent around your patio, deck or campsite to create a zone of mosquito protection while you're spending time outdoors. Easy-to-use, all-weather citronella products, such as the American Holiday-themed Cutter® CitroGuard® Triple Wick Candle, use the natural repelling properties of citronella oil to repel mosquitoes and other flying bugs. If you're camping out or picnicking, bringing along an area fogger such as Cutter® Backyard™ Bug Control Outdoor Fogger can give you several hours of mosquito protection. Just spray infested areas or surfaces and allow the fog to drift over the area.

For more information about West Nile virus and ways to protect against mosquitoes, visit www.cdc.gov/westnile. To learn more about Cutter® products, visit www.cutterinsectrepellent.com.

About United Industries

United Industries Corporation, a Spectrum Brands Company, is the leading manufacturer of value-brand consumer products for the home, lawn and garden insect and weed control markets in the United States. The company offers innovative products of outstanding quality, so consumers benefit from easier insect and weed control solutions. The brands — Spectracide®, Garden Safe®, Hot Shot®, Cutter®, Repel® and Black Flag® — are well recognized by consumers for delivering exceptional value and trusted results. For more information, visit www.UnitedIndustriesCorporation.com.

About Spectrum Brands Holdings, Inc.

Spectrum Brands Holdings (NYSE: SPB), a member of the Russell 2000 Index, is a global and diversified consumer products company and a leading supplier of consumer batteries, residential locksets, residential builders' hardware, faucets, shaving and grooming products, personal care products, small household appliances, specialty pet supplies, lawn and garden and home pest control products, and personal insect repellents. Helping to meet the needs of consumers worldwide, our Company offers a broad portfolio of market-leading, well-known and widely trusted brands including Rayovac®, Kwikset®, Weiser®, Baldwin®, National Hardware®, Pfister™, Remington®, VARTA®, George Foreman®, Black & Decker®, Toastmaster®, Farberware®, Tetra®, Marineland®, Nature's Miracle®, Dingo®, 8-in-1®, FURminator®, Littermaid®, Spectracide®, Cutter®, Repel®, Hot Shot® and Black Flag®. Spectrum Brands' products are sold by the world's top 25 retailers and are available in more than one million stores in approximately 140 countries. Spectrum Brands Holdings generated net sales of approximately $3.25 billion in fiscal 2012. On a pro forma basis following the Company's December 2012 acquisition of the Hardware & Home Improvement Group (HHI) from Stanley Black & Decker, Spectrum Brands had net sales of more than $4 billion for fiscal 2012. For more information, visit www.spectrumbrands.com.

Media contact:
Connie Caldwell, United Industries Corp.
314-683-2460, connie.caldwell@spectrumbrands.com

SOURCE United Industries Corporation

Source: www.prnewswire.com

Should everyone over 65 take a statin?

Should everyone over 65 take a statin?
Even seniors without known cardiovascular disease may benefit from cholesterol-lowering drugs, a new study suggests.

Wednesday, August 28, 2013

Greatist Workout of the Day: Wednesday August 28th

08/28/2013 - 10:05am by The Greatist Team

Welcome to the cycle of GWODs designed by Kelvin Gary and Katherine Simmons of Body Space Fitness! Note: Exercise descriptions with video links are included below the image.

Have thoughts on the new graphic design of Greatist's Workouts of the Day? Email us at gwod [at] greatist.com!

· Here’s a video demonstrating the squat to press.

· There’s a lot more to bodyweight squats than you think! Learn good squatting form to get those most out of your bodyweight squats.

· Understand the difference between wide grip lat pull-downs and narrow grip lat pulldowns.

Track it on Cody using the #imagreatist hashtag.

Tuesday, August 27, 2013

Smile Makeover Experts, Dr. Hakimzadeh and Dr. Reyhani, Featured in Cosmo and Angeleno Magazines

WEST HILLS, Calif., Aug. 27, 2013 /PRNewswire/ -- The dentists operating out of West Hills Smiles, a top-notch office specializing in concierge dentistry, are spreading the word about their signature approach to their craft. With two spreads in popular magazines out this month, Ben Reyhani, DDS and Pasha Hakimzadeh, DDS share their feelings on a broad range of topics, from anti-aging tips to restorative dentistry techniques. The full-page layouts also help establish the smile makeover experts as authorities in the field of cosmetic dentistry for style-minded patients.

The first one was published in the September issue of the style bible for many women, Cosmopolitan. Behind the cover graced by Nina Dobrev lies a page on "the Smile of Your Dreams" featuring the beaming faces of Dr. Ben and Dr. Pasha. Here, the pair answers common questions that they've most likely heard from many patients:

"How can I get whiter teeth?"
"Is it easy to straighten teeth?"
"What can I do if I have larger gaps and unevenly crooked teeth?"

The West Hills Smiles resident dentists then explain their smile makeover treatment methods for each of these questions. Whiter teeth, up to 4 shades, can be achieved through "a simple in-office power whitening" followed up with home care, most likely through take-home trays or standard good dental habits. For straighter teeth, the doctors promote their clear braces treatment, which is less invasive than metal brackets and can even be removed for important events. Finally, they describe their complete dental makeover plan in response to the last question, performed by strategic and effective use of porcelain veneers.

The second ad targets a more local niche. Featured in the August issue of Angeleno, the Los Angeles-based title from Modern Luxury, an interview with Dr. Pasha proffers "solutions for an aging face." The spread highlights the dental issues that come with age and their often unattractive impact of maturing a patient's appearance. Changes in smiles as we age, including shorter teeth, altered bite, and loss of tautness of the skin around our mouths, are offered minimally-invasive solutions by Dr. Pasha. Through an approach that differs for each patient and respects their individuality, a West Hills Smiles patient can take years off of his or her appearance. This most commonly means utilizing a combination of veneers, gum reshaping, tooth whitening, replacing metal amalgam fillings with tooth-colored materials, and other cosmetic dental treatments.

To experience dentistry fresh out of the pages of your favorite luxury or fashion magazine, contact the West Hills Smiles team to schedule a consultation with Dr. Ben or Dr. Pasha at your earliest convenience. The doctors always prioritize the comfort of their patients, both in office and through their treatments, prioritizing conservative and preventative methods ahead of invasive surgical means with every single patient. Call West Hills Smiles today at 747-800-4108 or go to www.WestHillsSmiles.com to learn more!

PR Submitted by www.cyberset.com

SOURCE West Hills Smiles

RELATED LINKS
http://www.westhillssmiles.com

Source: www.prnewswire.com

Why do haters have to hate?

Research has delved into the reasons why some people seem to dislike everything and others like everything. Read more...

Monday, August 26, 2013

How to Get Help When You Are Overweight

Whether you are already overweight or beginning to show signs of overweight, there is need for you to do something about it. Overweight normally comes from lifestyle. This can be ones eating habits or lack of enough exercises. Continue reading...

Cell phones used to measure happiness

Researchers are developing ways to use mobile phones to explore how one’s environment influences one’s sense of well-being. For full post, click here.

Cooking Light: Now I'm Obsessed With Walking 10,000 Steps a Day

For complete story, click here.

Healthy Habits to Lose Weight

Anyone who has tried to lose weight, knows it is not easy. It takes motivation, will power, self control, and determination. Not to mention it takes change. To successfully drop the weight you need to change your lifestyle habits. You cannot continue to eat the same way or do the same things because that won't change anything. If you really want to lose weight you need to impose healthy habits not only with eating but with exercising too. Here is the full post.

Is Your Weight Loss Program Producing Slow and Unnoticeable Results?

Is Your Weight Loss Program Producing Slow and Unnoticeable Results?
Do you feel that all of your straining workouts and depriving diet programs slowly or does not produce any result at all? It is a very common problem most people who try to lose weight ...

Sunday, August 25, 2013

Ovarian cancer test 'has potential'

Ovarian cancer test 'has potential'
A new method of screening for ovarian cancer is showing "potential", according to researchers in the US.

Fears of food and water poisoning after Damascus gassings

(This story was reported by a journalist whose name has been withheld for security reasons) DAMASCUS (Reuters) - Days after a suspected poison gas attack killed hundreds of people in crop-growing suburbs, residents of the Syrian capital say they are afraid their food and water supplies may be contaminated. Western countries believe President Bashar al-Assad's forces carried out the worst chemical weapons attack since Iraqi leader Saddam Hussein gassed thousands of Kurds in 1988. Syria's government denies any role in the deaths and blames rebels. ...

For full post, click here.

NHS pay-offs top £1bn, says Labour

Labour accuse the government of wasting £1.4bn on NHS redundancy packages, but ministers say they have to cut an "over-bloated bureaucracy". For complete story, click here.

Saturday, August 24, 2013

Correct Garcinia Cambogia Dosage Is Very Important!

It doesn't matter what it is that you are ingesting; you want to know what the proper amounts are for your personal physique. Especially when it comes to health and weight loss supplements such as Garcinia Cambogia, dosage is extremely important. It may be necessary for you to speak with a health professional or a nutritionist to know what your specific dosage is, but for the most part, it is the same across the board. Read more...

Carers should 'get flexible hours'

Carers should 'get flexible hours'
The UK faces a "lose-lose situation" if workers who care for elderly parents are not offered flexible working hours, the health secretary says.

Friday, August 23, 2013

What’s your story?

Everyone has one. Watching ‘Welcome to the World of Weight Loss’ really bought that home for me. We are so quick to judge, yet have no idea why a person has ended up where they have – be that overweight, an alcoholic, a drug user… Everyone who attends a weight loss group wants to lose

Marc Jacobs Beauty Magic Marc’er Precision Pen Eyeliner Review

The new Marc Jacobs Beauty cosmetic line includes the Marc Jacobs Beauty Magic Marc’er Precision Pen Eyeliner ($30 USD / $36 CAD), a black, felt-tip liquid eyeliner.. Marc Jacobs Beauty will be available exclusively at Sephora and Marc Jacobs stores on August 9, 2013 and is inspired by the spirit of youth, confidence and experimentation. I already posted […]

Marc Jacobs Beauty Magic Marc’er Precision Pen Eyeliner

The new Marc Jacobs Beauty cosmetic line includes the Marc Jacobs Beauty Magic Marc’er Precision Pen Eyeliner ($30 USD / $36 CAD), a black, felt-tip liquid eyeliner.. Marc Jacobs Beauty will be available exclusively at Sephora and Marc Jacobs stores on August 9, 2013 and is inspired by the spirit of youth, confidence and experimentation.

I already posted a review of this eyeliner in which I was very disappointed. I definitely received a defective eyeliner, and since I was one of the first to actually try the product, I had no idea that so many people loved this eyeliner (or else I would have assumed sooner). The one I had was defective in that it still worked, so it didn’t seem defective… it just seemed like an awful eyeliner! I have since received a new one, and I’m happy to re-publish this review with my updated thoughts.

Marc Jacobs Beauty Magic Marc’er Precision Pen Eyeliner

This eyeliner comes in a long, sleek black lacquered pen with a felt-tip applicator. It’s a very beautiful, elegant and artistic-looking product. The applicator is quite stiff and comes to an ultra-precise point, which is great for detail work like getting into the inner corner and creating a perfect cat-eye flick. The harder you press, the thicker the line, the lighter you press, the thinner the line- almost like a calligraphy pen. This is where my original eyeliner failed- it applied the eyeliner with a lot of pressure, but not when you used it lightly (therefore it went on super patchy and messy).

The eyeliner formula is very liquidy, although still ultra black and pigmented. It dries fairly quickly, and it’s completely waterproof- there’s no budging this eyeliner until you remove it with an oil-based makeup remover. I’m still playing with it to see if it will replace my beloved Lancôme Artliner- so far, it’s looking pretty good for Marc!

I’m happy to say this eyeliner is a complete dream to work with- and thank you to all of you who suggested I try out another one!

Marc Jacobs Beauty Magic Marc’er Precision Pen Eyeliner